Adicet Bio, Inc. — Director's Dealing 2023

Feb 15, 2023

SEC Form 5 — Annual Statement of Changes in Beneficial Ownership

Issuer: Adicet Bio, Inc. (ACET)
CIK: 0001720580
Period of Report: 2022-12-31

Reporting Person: Schor Chen (Director, President & CEO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2022-09-13	Common Stock	G	26712	$0.00	Disposed	64757	Direct
2022-09-13	Common Stock	G	26712	$0.00	Acquired	26712	Indirect
2022-09-27	Common Stock	G	26712	$0.00	Disposed	0	Indirect
2022-09-27	Common Stock	G	26712	$0.00	Acquired	91469	Direct
2022-09-28	Common Stock	G	26712	$0.00	Disposed	64757	Direct
2022-09-28	Common Stock	G	26712	$0.00	Acquired	26712	Indirect
2022-10-17	Common Stock	G	26712	$0.00	Disposed	38045	Direct
2022-10-17	Common Stock	G	26712	$0.00	Acquired	53424	Indirect
2022-11-14	Common Stock	G	9955	$0.00	Disposed	43469	Indirect
2022-11-14	Common Stock	G	9955	$0.00	Acquired	48000	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	53424	Indirect

Footnotes

F1: Represents shares held directly by The I. Schor IRRV Trust, an irrevocable family trust having an independent trustee.

F2: Represents shares held directly by The C. Schor IRRV Trust, an irrevocable family trust having an independent trustee.